Anne Frese
Responsable des Ressources Humaines chez MEI PHARMA, INC.
Postes actifs de Anne Frese
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MEI PHARMA, INC. | Responsable des Ressources Humaines | 22/06/2022 | - |
Historique de carrière de Anne Frese
Anciens postes connus de Anne Frese
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Artiva Biotherapeutics, Inc.
 Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Responsable des Ressources Humaines | 01/01/2019 | 01/07/2021 |
| BELLICUM PHARMACEUTICALS, INC. | Responsable des Ressources Humaines | 01/03/2015 | 01/07/2018 |
Vyripharm Enterprises LLC
 Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Responsable des Ressources Humaines | - | - |
Formation de Anne Frese
| McGill University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Canada | 2 |
Opérationnelle
| Human Resources Officer | 4 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEI PHARMA, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Vyripharm Enterprises LLC
Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Anne Frese
- Expérience
